Science & Technology
Global R&D

ST PHARM's mRNA Center
LEVATIO Therapeutics / VERNAGEN

LEVATIO Therapeutics

Innovative RNA therapeutics to heal diseases.
LEVATIO THERAPEUTICS is a biotech startup that seeks to deliver 'LEVATIO' to patients and their families through the development of innovative RNA therapeutics to heal diseases.

Mission and Goal

“Based on novel mRNA platform technology,
we develop next generation of cancer vaccine and CAR-NKT cell to treat cancers and autoimmune disease”

ST PHARM's
Goal

Cancers
  • Develop mRNA cancer vaccines for HPV E6/E7 antigens and neoantigens by using mRNA technology
  • Develop 'Off-the-Shelf' CAR-NKT therapy using mRNA therapeutics cancer vaccine and CAR-NKT cell to treat cancers and autoimmune disease”
Autoimmune Diseases
  • Develop 'Off-the-Shelf' CAR-NKT cells using mRNA therapeutics to treat autoimmune diseases including rheumatoid arthritis, inflammatory bowel diseases and multiple sclerosis.

Data-Driven Strategy

First-in-Class mRNA Therapeutics
  • Development of first-in-class mRNA cancer vaccine and customized neoantigen vaccine
  • 'Off-the-Shelf' CAR-NKT cells engineered with mRNA
Proof-of-Concept (POC)
  • Strong data-driven POC modality validating potential of proprietary mRNA technology and therapeutic application
Expansion of Pipeline
  • mRNA platform technology for developing cancer vaccines and 'Off-the-Shelf' CAR-NKT cells
  • Cancer and autoimmune disease
Collaborations
  • Open innovation strategy with academy, hospital, and research institute
  • Synergistic collaborations with ST PHARM in Korea

Contact

VERNAGEN

VERNAGEN is a biotech startup
that develops prophylactic vaccine & therapeutics based mRNA platform in Atlanta, USA.
mRNA Vaccines for infection diseases
  • RSV Vaccines
  • Norovirus Vaccines
  • Fatal Virus Vaccines (SFTS, Hendra/Nipah, Zika virus)
Pipeline Expansion
  • Rare diseases (profitability)
  • Alternatives for protein biologics
Strategic Collaborations
  • Open innovation (Universities, Hospitals, Lab etc.)
  • ST PHARM (mRNA Platform)
HOMEScience & TechnologyR&DGlobal R&D
© 2024 ST Pharm. All rights reserved.